228 related articles for article (PubMed ID: 28062498)
1. Novel Thrombotic Function of a Human SNP in STXBP5 Revealed by CRISPR/Cas9 Gene Editing in Mice.
Zhu QM; Ko KA; Ture S; Mastrangelo MA; Chen MH; Johnson AD; O'Donnell CJ; Morrell CN; Miano JM; Lowenstein CJ
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):264-270. PubMed ID: 28062498
[TBL] [Abstract][Full Text] [Related]
2. Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.
Zhu Q; Yamakuchi M; Ture S; de la Luz Garcia-Hernandez M; Ko KA; Modjeski KL; LoMonaco MB; Johnson AD; O'Donnell CJ; Takai Y; Morrell CN; Lowenstein CJ
J Clin Invest; 2014 Oct; 124(10):4503-16. PubMed ID: 25244095
[TBL] [Abstract][Full Text] [Related]
3. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
[TBL] [Abstract][Full Text] [Related]
4. Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.
van Loon JE; Sanders YV; de Wee EM; Kruip MJ; de Maat MP; Leebeek FW
PLoS One; 2012; 7(7):e40624. PubMed ID: 22792389
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients.
Lind-Halldén C; Manderstedt E; Carlberg D; Lethagen S; Halldén C
Thromb Haemost; 2018 Aug; 118(8):1382-1389. PubMed ID: 29972863
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
[TBL] [Abstract][Full Text] [Related]
7. Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk.
van Loon JE; Leebeek FW; Deckers JW; Dippel DW; Poldermans D; Strachan DP; Tang W; O'Donnell CJ; Smith NL; de Maat MP
Circ Cardiovasc Genet; 2010 Dec; 3(6):507-12. PubMed ID: 21156930
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.
Huang J; Huffman JE; Yamakuchi M; Trompet S; Asselbergs FW; Sabater-Lleal M; Trégouët DA; Chen WM; Smith NL; Kleber ME; Shin SY; Becker DM; Tang W; Dehghan A; Johnson AD; Truong V; Folkersen L; Yang Q; Oudot-Mellkah T; Buckley BM; Moore JH; Williams FM; Campbell H; Silbernagel G; Vitart V; Rudan I; Tofler GH; Navis GJ; Destefano A; Wright AF; Chen MH; de Craen AJ; Worrall BB; Rudnicka AR; Rumley A; Bookman EB; Psaty BM; Chen F; Keene KL; Franco OH; Böhm BO; Uitterlinden AG; Carter AM; Jukema JW; Sattar N; Bis JC; Ikram MA; ; Sale MM; McKnight B; Fornage M; Ford I; Taylor K; Slagboom PE; McArdle WL; Hsu FC; Franco-Cereceda A; Goodall AH; Yanek LR; Furie KL; Cushman M; Hofman A; Witteman JC; Folsom AR; Basu S; Matijevic N; van Gilst WH; Wilson JF; Westendorp RG; Kathiresan S; Reilly MP; ; Tracy RP; Polasek O; Winkelmann BR; Grant PJ; Hillege HL; Cambien F; Stott DJ; Lowe GD; Spector TD; Meigs JB; Marz W; Eriksson P; Becker LC; Morange PE; Soranzo N; Williams SM; Hayward C; van der Harst P; Hamsten A; Lowenstein CJ; Strachan DP; O'Donnell CJ;
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1093-101. PubMed ID: 24578379
[TBL] [Abstract][Full Text] [Related]
10. Interaction networks of Weibel-Palade body regulators syntaxin-3 and syntaxin binding protein 5 in endothelial cells.
Schillemans M; Karampini E; Hoogendijk AJ; Wahedi M; van Alphen FPJ; van den Biggelaar M; Voorberg J; Bierings R
J Proteomics; 2019 Aug; 205():103417. PubMed ID: 31201948
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis.
Smith NL; Rice KM; Bovill EG; Cushman M; Bis JC; McKnight B; Lumley T; Glazer NL; van Hylckama Vlieg A; Tang W; Dehghan A; Strachan DP; O'Donnell CJ; Rotter JI; Heckbert SR; Psaty BM; Rosendaal FR
Blood; 2011 Jun; 117(22):6007-11. PubMed ID: 21163921
[TBL] [Abstract][Full Text] [Related]
12. A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research.
Miano JM; Zhu QM; Lowenstein CJ
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1058-75. PubMed ID: 27102963
[TBL] [Abstract][Full Text] [Related]
13. The Implications of CRISPR-Cas9 Genome Editing for IR.
Perkons NR; Sheth R; Ackerman D; Chen J; Saleh K; Hunt SJ; Nadolski GJ; Shi J; Gade TP
J Vasc Interv Radiol; 2018 Sep; 29(9):1264-1267.e1. PubMed ID: 30146193
[No Abstract] [Full Text] [Related]
14. Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the future.
Mao XY; Dai JX; Zhou HH; Liu ZQ; Jin WL
Oncotarget; 2016 May; 7(22):33461-71. PubMed ID: 26993776
[TBL] [Abstract][Full Text] [Related]
15. A Potential Role for the STXBP5-AS1 Gene in Adult ADHD Symptoms.
Arias-Vásquez A; Groffen AJ; Spijker S; Ouwens KG; Klein M; Vojinovic D; Galesloot TE; Bralten J; Hottenga JJ; van der Most PJ; Kattenberg VM; Pool R; Nolte IM; Penninx BWJH; Fedko IO; Dolan CV; Nivard MG; den Braber A; van Duijn CM; Hoekstra PJ; Buitelaar JK; Kiemeney LA; Hoogman M; Middeldorp CM; Draisma HHM; Vermeulen SH; Sánchez-Mora C; Ramos-Quiroga JA; Ribasés M; ; Hartman CA; Kooij JJS; Amin N; Smit AB; Franke B; Boomsma DI
Behav Genet; 2019 May; 49(3):270-285. PubMed ID: 30659475
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.
Chadwick AC; Musunuru K
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):12-18. PubMed ID: 28838920
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide association studies identify genetic loci for low von Willebrand factor levels.
van Loon J; Dehghan A; Weihong T; Trompet S; McArdle WL; Asselbergs FW; Chen MH; Lopez LM; Huffman JE; Leebeek FW; Basu S; Stott DJ; Rumley A; Gansevoort RT; Davies G; Wilson JJ; Witteman JC; Cao X; de Craen AJ; Bakker SJ; Psaty BM; Starr JM; Hofman A; Wouter Jukema J; Deary IJ; Hayward C; van der Harst P; Lowe GD; Folsom AR; Strachan DP; Smith N; de Maat MP; O'Donnell C
Eur J Hum Genet; 2016 Jul; 24(7):1035-40. PubMed ID: 26486471
[TBL] [Abstract][Full Text] [Related]
18. Multiplexed conditional genome editing with Cas12a in
Port F; Starostecka M; Boutros M
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348
[TBL] [Abstract][Full Text] [Related]
19. Efficient generation of goats with defined point mutation (I397V) in GDF9 through CRISPR/Cas9.
Niu Y; Zhao X; Zhou J; Li Y; Huang Y; Cai B; Liu Y; Ding Q; Zhou S; Zhao J; Zhou G; Ma B; Huang X; Wang X; Chen Y
Reprod Fertil Dev; 2018 Jan; 30(2):307-312. PubMed ID: 28692815
[TBL] [Abstract][Full Text] [Related]
20. SNP-CRISPR: A Web Tool for SNP-Specific Genome Editing.
Chen CL; Rodiger J; Chung V; Viswanatha R; Mohr SE; Hu Y; Perrimon N
G3 (Bethesda); 2020 Feb; 10(2):489-494. PubMed ID: 31822517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
